BiotechnologyPharmaceuticals Neumirna raises €20m, will begin clinical trials for its epilepsy drug by David Mitchell January 12, 2025 by David Mitchell January 12, 2025 2 minutes read Neumirna Secures €20m Funding for Epilepsy Drug Clinical Trials The landscape of biotechnology is …
